LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance

U.S. Markets close in 40 mins.

Eli Lilly and Company (LLY)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
83.96+1.15 (+1.39%)
As of 3:20PM EST. Market open.
People also watch
BMYMRKABTGSKJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close82.81
Open83.44
Bid0.00 x
Ask0.00 x
Day's Range82.97 - 84.14
52 Week Range64.18 - 84.14
Volume2,360,424
Avg. Volume4,950,000
Market Cap88.23B
Beta0.24
PE Ratio (TTM)32.57
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.50%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist6 hours ago

    A Look at Incyte’s Product Portfolio

    Incyte has classified its oncology product portfolio into targeted anti-cancer therapies and immuno-oncology or immunotherapies.

  • Lilly Completes Acquisition of CoLucid Pharmaceuticals
    PR Newswire7 hours ago

    Lilly Completes Acquisition of CoLucid Pharmaceuticals

    INDIANAPOLIS, March 1, 2017 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (CLCD). The tender offer for all outstanding shares of common stock of CoLucid, at a price of $46.50 per share, expired as scheduled on Tuesday, February 28, 2017. As of the expiration of the tender offer, 17,410,607 shares of CoLucid common stock were validly tendered, representing approximately 90.3 percent of the shares outstanding, and have been accepted for payment under the terms of the tender offer.

  • TheStreet.com20 hours ago

    Cramer: This Drug Rally Is No Longer 'Trumped Up'

    Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.